A detailed history of Superstring Capital Management LP transactions in Zai Lab LTD stock. As of the latest transaction made, Superstring Capital Management LP holds 294,947 shares of ZLAB stock, worth $11.2 Million. This represents 12.68% of its overall portfolio holdings.

Number of Shares
294,947
Previous 403,630 26.93%
Holding current value
$11.2 Million
Previous $10.6 Billion 0.84%
% of portfolio
12.68%
Previous 9.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

SELL
$24.29 - $38.35 $2.64 Million - $4.17 Million
-108,683 Reduced 26.93%
294,947 $10.7 Billion
Q4 2024

Feb 14, 2025

SELL
$24.61 - $33.18 $5.5 Million - $7.41 Million
-223,302 Reduced 35.62%
403,630 $10.6 Billion
Q3 2024

Nov 14, 2024

BUY
$16.25 - $24.14 $6.69 Million - $9.94 Million
411,754 Added 191.36%
626,932 $15.1 Billion
Q2 2024

Aug 14, 2024

BUY
$13.72 - $21.55 $2.95 Million - $4.64 Million
215,178 New
215,178 $3.73 Billion

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.71B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Superstring Capital Management LP Portfolio

Follow Superstring Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Superstring Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Superstring Capital Management LP with notifications on news.